TrialBritish journal of cancer2013

Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib.

Y-K Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.